Our Recommendations
- Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors (2023)
- Tropical Medicine Point-of-Care Testing. Update 2022 (2022)
- Clinical management of COVID-19: living guideline, 23 June 2022 (Arabic) (2022)
- Manejo clínico de la COVID-19: orientaciones evolutivas, 23 de junio de 2022 (2022)
- Manual de Biossegurança Laboratorial (2021)
New Publications
- Therapeutics and COVID-19 (Living Guideline, 10 November 2023) (2023)
- Voluntary non-remunerated blood donations to ensure blood safety in the WHO South-East Asia Region to support universal health coverage (2023)
- Clinical management of COVID-19: Living guideline, 18 August 2023 (2023)
- Drugs to prevent COVID-19: living guideline (2023)
- Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors (2023)
Filter
550
Featured
Recommendations
140
New Publications
3
Language
Document type
Guidelines
283
Fact sheets
90
Studies & Reports
55
Manuals
41
Infographics
22
Videos
14
Resource Platforms
13
Online Courses
13
Training Material
10
Situation Updates
5
Brochures
2
No document type
2
Countries / Regions
Russia
50
Brazil
44
Germany
29
Latin America and the Carribbean
27
Middle East and North Africa
22
Mozambique
21
West and Central Africa
21
Angola
21
Guinea-Bissau
16
East and Southern Africa
16
Africa
13
Global
11
Syria
10
Eastern Europe and Central Asia
10
Yemen
10
Spain
9
South Africa
7
Western and Central Europe
5
Eastern Europe
5
Ecuador
5
India
4
Western Pacific Region
3
France
3
Argentina
3
Vietnam
3
South Sudan
3
Ukraine
2
Kazakhstan
2
Nigeria
2
Philippines
2
Haiti
2
South–East Asia Region
2
Portugal
2
Sudan
2
Nepal
1
Switzerland
1
El Salvador
1
Turkey
1
Benin
1
Togo
1
China
1
Cameroon
1
Canada
1
Laos
1
Senegal
1
Congo-Brazzaville
1
Niger
1
Burkina Faso
1
Burundi
1
Austria
1
Italy
1
Cambodia
1
Venezuela
1
Saudi Arabia
1
Luxembourg
1
Belgium
1
United Kingdom
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Bangladesh
1
Djibouti
1
Central African Republic
1
Ethiopia
1
Mali
1
Chad
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
224
Clinical Guidelines
31
Pharmacy & Technologies
21
Women & Child Health
16
Capacity Building
9
Key Resources
4
Public Health
2
Update, 23 de junio de 2022
Tuberculosis (TB) is the deadliest infectious disease in most low- and middle-income countries, claiming more than 4,000 lives each day. The unprecedented COVID-19 pandemic has seriously impacted people with pre-existing health conditions. People with TB are usually more vulnerable to other infectio...
For patients on HFNO with persistent hypoxaemia or respiratory distress:
• Check the equipment: inspect the exterior of the machine, the tubing (circuit), the prong for any sign of mechanical damage, confirm it fits and the filters are in place. Ensure the settings are appropriate and flow is max...
During ventilation and between patients
Always read and follow the instructions and recommendations of the manufacturer`s manual
Consumables associated with oxygen delivery are generally intended as single use devices, and should be treated as infectious material and disposed of accordingly. Dispo...
Multiple countries are reporting severe acute cases of hepatitis of unknown aetiology in children, in several
regions of the world. WHO has developed this clinical case report form (CRF) to support and facilitate reporting
of anonymized, patient-level data of acute hepatitis of unknown aetiology.
22 July 2022. This document provides the case definitions for public health surveillance of COVID-19 in humans caused by SARS-COV-2 infection.
11 May 2022
What are WHO's recommendations for COVID-19 vaccines and children? And what does the evidence say so far about the safety of these vaccines in children? And if you live in a country where this vaccination is not available for your kids, how can you keep them safe? WHO’s Dr Soumya Swa...
List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022
Revised COVID-19 Testing Strategy
recommended
Second edition. June 2022. This revised guidance recommends that access to COVID-19 testing is decentralized as far as possible and made available at health facilities, and through the use of self tests to enable access to care and the mitigation of transmission. Testing should be prioritized for hi...
4 march 2022
What have we learned about the symptoms of Long COVID or Post COVID-19 condition so far? How long does it last, when should you worry, and what treatments are recommended? WHO’s Dr Janet Diaz explains in Science in 5.
he Framework sets the requirements for facilities handling High Consequence Agents and Toxins (HCATs) and guides the implementation of laboratory biosafety and biosecurity practices associated with the design, commissioning, routine operation safe and secure biocontainment laboratories.
Los coronavirus son un grupo de virus ARN altamente diversos de la familia Coronaviridae que se dividen en
4 géneros: alfa, beta, gamma y delta, y que causan enfermedades de leves a graves en humanos y animales
(1-3). Existen coronavirus humanos endémicos como los alfacoronavirus 229E y NL63 y l...
Updated 2022. This guide addresses the care pathway from presentation of the patient to a health facility to patient discharge. It considers different levels of disease severity, from asymptomatic individuals to critically ill patients. Accounting for variations in the benefits and harms of chest im...
For patients on NIPPV or HFNO with persistent hypoxaemia or respiratory distress:
• Check the equipment: inspect the exterior of the machine, the tubing (circuit), the mask for any sign of mechanical damage, confirm it fits securely without leak (if CPAP/BiPAP) and the filters are in place. Ensur...
Molnupiravir for COVID-19
recommended
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
Update, 23 de junio de 2022
The World Health Organization (WHO) recognizes the challenges countries face for maintaining their COVID-19 response while addressing competing public health challenges, conflicts, climate change and economic crises.
It remains critical for national programmes to continue to offer testing for COVI...
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us...
